Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Martin Vogelbaum Insider Profile
4 Followers
Martin Vogelbaum, Director at Cara Therapeutics, holds 109.71K shares in Cara Therapeutics (Ticker: CARA), holds 0.00 shares in Rocket Pharmaceuticals (Ticker: RCKT), holds 1.33M shares in NephroGenex (Ticker: NRXGQ).
Profitable Transactions
4 out of 4 Profitable Transactions
Average Return
+71.70%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Martin Vogelbaum holds in companies
Most Profitable Insider Trade
The most profitable trade made by Martin Vogelbaum
Martin Vogelbaum's Trading History
Cara Therapeutics
Jun 05, 2023
Director
Uninformative Buy
―
$77.57K
Rocket Pharmaceuticals
―
Director
―
$0.00
NephroGenex
Feb 19, 2014
―
Uninformative Buy
―
$18.58K
Arca Biopharma
―
Director
―
$0.00
List of latest transactions for each holding click on a transaction to see Martin Vogelbaum's performance on stock
You May Also Like
Martin Vogelbaum insider profile FAQ
What is the percentage of profitable transactions made by Martin Vogelbaum?
The percentage of profitable transactions made by Martin Vogelbaum is 100%.
What is the average return per transaction made by Martin Vogelbaum?
The average return per transaction made by Martin Vogelbaum is 71.70%.
What stocks does Martin Vogelbaum hold?
Martin Vogelbaum holds: CARA, RCKT, NRXGQ, ABIO stocks.
What was Martin Vogelbaum’s latest transaction?
Martin Vogelbaum latest transaction was an Uninformative Buy of ―.
What was Martin Vogelbaum's most profitable transaction?
Martin Vogelbaum’s most profitable transaction was an Informative Buy of CARA stock on March 18, 2016. The return on the trade was 195.30%.
What is Martin Vogelbaum's role in Cara Therapeutics?
Martin Vogelbaum's role in Cara Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.